Metraipolis › archive › dc_28152d4d0fdb

Anlotinib combined with temozolomide for brain metastases in small cell lung cancer with early recurrence after whole-brain radiotherapy: a case report — Europe PMC PMID:42180771

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42180771
DOI
10.3389/fmed.2026.1824583
License (as archived)
solo-consultazione
Archived
2026-11-02T14:56:51.670Z
SHA-256 of the archived text
d8ee405e9b60f10804848dc05ec566cf1b1534b2b3bd97f3e1a1988a308d65d1
Stable URL of this page
https://metraipolis.com/documento/dc_28152d4d0fdb

How to cite

Anlotinib combined with temozolomide for brain metastases in small cell lung cancer with early recurrence after whole-brain radiotherapy: a case report — Europe PMC PMID:42180771 — Europe PMC (en), https://europepmc.org/article/MED/42180771 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_28152d4d0fdb (Metraipolis archive dc_28152d4d0fdb, sha256 d8ee405e9b60f10804848dc05ec566cf1b1534b2b3bd97f3e1a1988a308d65d1)
BibTeX
@misc{dc28152d4d0fdb,
  title = {Anlotinib combined with temozolomide for brain metastases in small cell lung cancer with early recurrence after whole-brain radiotherapy: a case report — Europe PMC PMID:42180771},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42180771},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_28152d4d0fdb; sha256 d8ee405e9b60f10804848dc05ec566cf1b1534b2b3bd97f3e1a1988a308d65d1},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42180771. Agents can read the archived copy with the MCP tool read_document.